Umifenovir

Spotlight

CSIR’s Central Drug Research Institute (CDRI) Lucknow Gets Nod For Conducting Clinical Ttrials Of Antiviral Drug Umifenovir

June 19, 2020 09:15
Healthwire Bureau

The CSIR — Central Drug Research Institute (CDRI) Lucknow, has received permission for carrying out clinical trial of antiviral drug Umifenovir for treating coronavirus patients. The Phase III clinical trials…

View Post

Latest News
Spotlight

Glenmark To Commence Another New Phase 3 Clinical Trial On A Combination Of Two Anti-Viral Drugs Favipiravir And Umifenovir

May 26, 2020 14:06
Healthwire Bureau

Glenmark Pharmaceuticals Ltd Glenmark has announced to commence another new phase 3 Clinical Trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19…

View Post

Menu

Umifenovir

CSIR’s Central Drug Research Institute (CDRI) Lucknow Gets Nod For Conducting Clinical Ttrials Of Antiviral Drug Umifenovir

Glenmark To Commence Another New Phase 3 Clinical Trial On A Combination Of Two Anti-Viral Drugs Favipiravir And Umifenovir

World Antimicrobial resistance (AMR) Awareness Week 2024

Cervical cancer elimination day of action

IIT Madras Study Reveals Oral Contraceptives Don’t Raise Blood Pressure in Female Athletes

Zilebesiran: Single Dose Shows Six-Month Blood Pressure Control in Hypertension Breakthrough

Fasting Enhances Glucose Regulation for Night Shift Employees: Study Finds

Parkinson’s Disease To Surge To 3.15 Million Worldwide By 2033: Warns Report

Experts Warn: Air Pollution Can Trigger Heart Attacks, Here’s How PM2.5 Can Cause Damage Arteries

Burning Eyes, Difficulty In Breathing: Toxic Delhi Smog And 500 AQI Levels Leave Residents Helpless